Advances on Epigenetic Drugs for Pediatric Brain Tumors

Pediatric malignant brain tumors represent the most frequent cause of cancer-related deaths in childhood. The therapeutic scheme of surgery, radiotherapy and chemotherapy has improved patient management, but with minimal progress in patients’ prognosis. Emerging molecular targets and mechanisms have...

Descripción completa

Detalles Bibliográficos
Autores principales: Skouras, Panagiotis, Markouli, Mariam, Strepkos, Dimitrios, Piperi, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Medicine, Neurology, Pharmacology, Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472812/
https://www.ncbi.nlm.nih.gov/pubmed/36154607
http://dx.doi.org/10.2174/1570159X20666220922150456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472812/
https://www.ncbi.nlm.nih.gov/pubmed/36154607
http://dx.doi.org/10.2174/1570159X20666220922150456

Ejemplares similares